Literature DB >> 24531870

Functioning and health-related quality of life in Chinese patients with systemic sclerosis: a case-control study.

P T Chan1, C C Mok, K L Chan, L Y Ho.   

Abstract

The objective of the study was to study the functioning and health-related quality of life (HRQoL) in patients with systemic sclerosis (SSc) and its associated factors. Consecutive SSc patients and an equal number of age- and gender-matched healthy controls were recruited for the assessment of functioning and HRQoL by the Health assessment questionnaire disability index (HAQ-DI) and Medical Outcomes Study Short Form 36 (SF-36), respectively. The extent of skin involvement of SSc was assessed by the modified Rodnan skin score (mRSS), and disease severity was assessed by the Medsger severity index. Factors associated with functioning and HRQoL in SSc patients were studied by linear regression. Seventy-eight Chinese SSc patients were studied (87 % women; age 50.2 ± 12.1 years; disease duration 7.8 ± 6.5 years; 81 % limited cutaneous subtype). The median mRSS of the patients was 8 (IQR 0-10). Patients with SSc had significantly higher HAQ-DI (0.69 ± 0.69 vs 0.04 ± 0.18; p < 0.001) but lower SF36 scores (p < 0.05 in all domains) than matched controls. Linear regression revealed that the mRSS was inversely associated with the physical component (beta = -0.39; p = 0.001) and mental component scores (beta = -0.27; p = 0.031) of the SF36 but positively correlated with the HAQ-DI score (beta = 0.51; p < 0.001) adjusted for age, sex, and disease duration. The SF36 and HAQ-DI scores also correlated significantly with the Medsger SSc severity index in the general, peripheral vascular, skin, tendon/joint, and heart domains. SSc patients had impaired physical and social functioning and poorer HRQoL than healthy individuals. The extent of skin involvement, tendon/joint contracture, damage in the heart, and peripheral vascular system were associated with poorer functioning and HRQoL.

Entities:  

Mesh:

Year:  2014        PMID: 24531870     DOI: 10.1007/s10067-014-2525-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  30 in total

Review 1.  Work status and its determinants among patients with systemic sclerosis: a systematic review.

Authors:  Anne A Schouffoer; Jan W Schoones; Caroline B Terwee; Theodora P M Vliet Vlieland
Journal:  Rheumatology (Oxford)       Date:  2012-03-15       Impact factor: 7.580

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  A meta-analysis of the effects of cognitive therapy in depressed patients.

Authors:  V Gloaguen; J Cottraux; M Cucherat; I M Blackburn
Journal:  J Affect Disord       Date:  1998-04       Impact factor: 4.839

4.  A disease severity scale for systemic sclerosis: development and testing.

Authors:  T A Medsger; A J Silman; V D Steen; C M Black; A Akesson; P A Bacon; C A Harris; S Jablonska; M I Jayson; S A Jimenez; T Krieg; E C Leroy; P J Maddison; M L Russell; R K Schachter; F A Wollheim; H Zacharaie
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

5.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

Review 6.  Scleroderma epidemiology.

Authors:  Maureen D Mayes
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

7.  Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis.

Authors:  L Mouthon; C Mestre-Stanislas; A Bérezné; F Rannou; P Guilpain; M Revel; C Pagnoux; L Guillevin; J Fermanian; S Poiraudeau
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

8.  Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions.

Authors:  Marie Hudson; Brett D Thombs; Russell Steele; Pantelis Panopalis; Evan Newton; Murray Baron
Journal:  J Rheumatol       Date:  2009-02-17       Impact factor: 4.666

9.  Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers.

Authors:  Angela Del Rosso; Maura Boldrini; David D'Agostino; Giovanni Plinio Augusto Placidi; Alessandra Scarpato; Alberto Pignone; Sergio Generini; Yrio Konttinen; Massimo Zoppi; Tonko Vlak; Gianfranco Placidi; Marco Matucci-Cerinic
Journal:  Arthritis Rheum       Date:  2004-06-15

10.  Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II.

Authors:  Marie Hudson; Brett D Thombs; Russell Steele; Rita Watterson; Suzanne Taillefer; Murray Baron
Journal:  Arthritis Rheum       Date:  2008-02-15
View more
  4 in total

1.  Effect of mycophenolate mofetil (MMF) on systemic sclerosis-related interstitial lung disease with mildly impaired lung function: a double-blind, placebo-controlled, randomized trial.

Authors:  G S R S N K Naidu; Shefali Khanna Sharma; M B Adarsh; Varun Dhir; Anindita Sinha; Sahajal Dhooria; Sanjay Jain
Journal:  Rheumatol Int       Date:  2019-12-07       Impact factor: 2.631

2.  Association of Musculoskeletal and Radiological Features with Clinical and Serological Findings in Systemic Sclerosis: A Single-Centre Registry Study.

Authors:  Nasrin Azarbani; Ali Javadzadeh; Iman Mohseni; Arash Jalali; Elham Andalib; Hadi Poormoghim
Journal:  Mediterr J Rheumatol       Date:  2020-09-30

3.  Comparison of clinical and serological parameters in female and male patients with systemic sclerosis.

Authors:  Ewa Wielosz; Maria Majdan; Magdalena Dryglewska; Dorota Suszek
Journal:  Reumatologia       Date:  2016-02-11

4.  Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study.

Authors:  Eun Hye Park; Vibeke Strand; Yoon Jeong Oh; Yeong Wook Song; Eun Bong Lee
Journal:  Arthritis Res Ther       Date:  2019-02-15       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.